Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
about
Opioid therapy pharmacogenomics for noncancer pain: efficacy, adverse events, and costsTramadol Extended-Release for the Management of Pain due to OsteoarthritisBasic review of the cytochrome p450 system.CYP2D6 in the metabolism of opioids for mild to moderate pain.Clinical Pharmacogenetics Implementation Consortium (CPIC) guidelines for codeine therapy in the context of cytochrome P450 2D6 (CYP2D6) genotypePharmacogenomic considerations in opioid analgesia.Recent advances in the use of opioids for cancer pain[Undesired side effects of tapentadol in comparison to oxycodone. A meta-analysis of randomized controlled comparative studies].Copy number variants in pharmacogenetic genes.Life-threatening adverse events following therapeutic opioid administration in adults: is pharmacogenetic analysis useful?Current evidence for a modulation of low back pain by human genetic variants.Pharmacogenetics in reproductive and perinatal medicine.Doing without codeine: why and what are the alternatives?Personalized therapy in pain management: where do we stand?Mechanism based medicine in infancy: complex interplay between developmental pharmacology and pharmacogenetics.Pain management in patients with cancer: focus on opioid analgesics.Extended-release formulations of tramadol in the treatment of chronic pain.A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project.Tramadol can selectively manage moderate pain in children following European advice limiting codeine use.Opioid-induced respiratory depression in the acute care setting: a compendium of case reports.The Pharmacogenetics of Tramadol.CYP2D6 genetic polymorphisms and their relevance for poisoning due to amfetamines, opioid analgesics and antidepressants.Pharmacogenomics and Opioid Analgesics: Clinical Implications.Personalizing supportive care in oncology patients using pharmacogenetic-driven treatment pathways.The role of cytochrome P450 pharmacogenomics in chronic non-cancer pain patients.Worldwide Distribution of Cytochrome P450 Alleles: A Meta-analysis of Population-scale Sequencing Projects.Review of Opioid Pharmacogenetics and Considerations for Pain Management.Opioid Analgesics and Nicotine: More Than Blowing Smoke.Fentanyl, rather than Tramadol: A cause of respiratory depression.PharmGKB summary: tramadol pathway.Individual variability in clinical effect and tolerability of opioid analgesics - Importance of drug interactions and pharmacogenetics.High frequency of occurrence of CYP2D6 gene duplication/multiduplication indicating ultrarapid metabolism among suicide cases.Pharmacogenetics of opiates in clinical practice: the visible tip of the iceberg.When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.Value of Supportive Care Pharmacogenomics in Oncology Practice.Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study.Cancer Pain Management: Opioid Analgesics, Part 2Toxicology of Specific Substances
P2860
Q21284753-61B1D650-BE58-45B4-9986-5FDE6304396DQ27015822-C2987EF0-9889-464C-9CB0-9160ACF9FDFAQ33886025-52DC8CEA-91C2-4425-BFB2-DDB1E741A8BCQ34178485-8EB25A97-4FFF-4662-9E21-45C386957E0AQ34243414-227A2D61-CBE6-4DBF-84F3-24717664C29FQ34316700-12A7EEAE-F879-4701-A420-F5C5A88377C4Q34418203-7729BD26-A3D9-44B1-84F8-4B4A5C16F007Q34636179-1F0E4167-C49B-4E3F-8ECF-48CCAB9ABCA2Q34975631-AAE6BC0A-B3A2-4332-AC63-F71D6BCC9CA0Q36905965-1B8B583D-C721-4CD1-8AF5-362C90A3DA26Q37396519-5C04544D-FA0F-4D1A-B760-9C2F988FB0FEQ37657531-9E6E7D54-321D-4862-A3D7-01FFE9835245Q37717471-6C741B80-80CF-4F9F-BC7D-770E65F9C742Q37760955-8106ADB2-B195-403F-A34A-E8B29CC7B252Q37858446-B1D09372-354B-47C5-AB9F-86B703D46A6DQ37863588-D0B0D5B1-1E50-4F5C-9E01-4BC3F7E7EAF5Q37879141-CE750655-D9E8-49E6-A0DE-623313C0A054Q37895002-86566062-8D91-4051-8B75-4727EA6F2444Q38231617-AAFBF93A-DEA2-415E-B463-8BA640442EFCQ38258532-5FDEF1A4-7D5A-4013-9993-FEA213CB95CDQ38441114-DAF55EE0-9402-473A-AA9F-50F1F30B882CQ38496627-B95692F4-237E-40B3-8790-5928638107E7Q38527869-753D4DDC-6FFA-4815-A02C-D78487BA9A07Q38731079-C32F796C-FED3-47C3-AF76-26FB22072AC9Q38844220-CD1BA340-CE31-4AE3-9D66-CEAB870F6CABQ38853651-D4D7D74E-9537-4F26-82BE-A473EAEBC041Q39430407-2EFA1BA1-C3C4-44F0-9D2D-9F7F342B7F29Q41353710-581F7FE6-F8DF-44AF-94E2-31D1A7E1E8C7Q41864490-ECF16E1F-74D7-4CD7-981D-6E631E31F14BQ42737748-F0527495-4606-45CE-8D42-A20D8161EC7CQ43075723-BA4660D5-EF48-4D52-89E3-B61F69E1915FQ43726094-BF67468E-EC3A-4897-95B4-16AD94A3197BQ48490118-32AB9749-44BB-41B1-9154-EFF8F184D045Q52349592-BDAC9928-EBC5-4F98-8BFA-D82F145D77AFQ52603826-3AE3A871-04A1-44B4-8433-CB05686A40A6Q54766895-935FC770-1248-4087-8EB9-D4DB2AE77E13Q57498749-F8F1D1D9-159F-4008-A4D0-7AB9A15C8EAAQ57986556-561EDF2E-751D-4D3D-9393-7D43F15C34F0
P2860
Respiratory depression with tramadol in a patient with renal impairment and CYP2D6 gene duplication.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Respiratory depression with tr ...... t and CYP2D6 gene duplication.
@en
type
label
Respiratory depression with tr ...... t and CYP2D6 gene duplication.
@en
prefLabel
Respiratory depression with tr ...... t and CYP2D6 gene duplication.
@en
P2093
P1476
Respiratory depression with tr ...... t and CYP2D6 gene duplication.
@en
P2093
Frank Stüber
Thomas Muders
Ulrike M Stamer
P304
P356
10.1213/ANE.0B013E31817B796E
P407
P577
2008-09-01T00:00:00Z